Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Schmitt C et al. – Administration of ritonavir–boosted saquinavir markedly increased the exposure of midazolam by inhibiting its metabolism, confirming that the combination of saquinavir and ritonavir at steady state strongly inhibits CYP3A4 activity.

Related Articles

Transrectal Ultrasound-Guided Prostatic Biopsy: Midazolam, the Ideal Analgesic
Urologia Internationalis, 10/16/09    Relevance Score: 88%

The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test
Pharmacogenetics and genomics, 10/30/09    Relevance Score: 84%

Comparative Evaluation of Ketamine, Midazolam and Combination of Both as Oral Premedicants in Children
Journal of Anaesthesiology Clinical Pharmacology, 10/12/09    Relevance Score: 84%

Combination therapy in the prevention of ponv after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone
Middle East Journal of Anesthesiology, 10/08/09    Relevance Score: 84%

Early Cognitive Impairment After Sedation for Colonoscopy: The Effect of Adding Midazolam and/or Fentanyl to Propofol
Anesthesia & Analgesia, 10/21/09    Relevance Score: 83%

Today in Basic Science...keeping you current

Expectations, validity, and reality in pharmacogenetics
Journal of Clinical Epidemiology, 12/10/09

Inhibitory effects of 1,3-thiazine derivatives on melanogenesis
Journal of Pharmacy and Pharmacology, 12/10/09

Review: physical chemistry of solid dispersions
Journal of Pharmacy and Pharmacology, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address